What is ALLE's health score?

Allegion plc (ALLE) has a TradeApes health score of 61 out of 100, rated Healthy. This composite score evaluates financial strength, operating trends, valuation, capital allocation, and risk factors.

What is ALLE's estimated fair value?

Based on our 5-year discounted cash flow model, Allegion plc's estimated fair value is $88.28 per share, representing a -32.1% downside from the current price. This is a model estimate, not a price target or investment recommendation.

Is ALLE undervalued or overvalued?

Our model currently rates ALLE as Overvalued. This assessment combines health metrics, valuation multiples, and market sentiment. Individual investors should conduct their own due diligence.

Crunching the numbers for ALLE... Refresh in a moment for the full analysis.

Allegion plc (ALLE)

Technology Overvalued low healthy

$130.07

Updated: 2026-06-01

TradeApes Score

Financial Strength

65 Healthy

Operating Trend

55 Mixed

Relative Value

63 Healthy

Capital Allocation

55 Mixed

Risk

70 Healthy

Est. Fair Value $88.28

DCF Upside -32.1%

Sector Rank #2152 of 7569

Key Findings

+ Free cash flow positive — business generates real spendable cash

Unlock Full Report →

− Altman Z-Score in grey zone — uncertain financial stability

Unlock Full Report →

1 free score card remaining

TradeApes provides financial data, analytics, and research tools. TradeApes is not a registered investment adviser, broker-dealer, or tax advisor. The information presented is for educational and informational purposes only and does not constitute investment, financial, or tax advice.

11 sector-leading stocks delivered to your inbox every Sunday. Free.

No spam. Unsubscribe anytime.